Sarcopenia, Frailty and Risk Prediction in Geriatric Patients episode artwork

EPISODE · Feb 9, 2017 · 18 MIN

Sarcopenia, Frailty and Risk Prediction in Geriatric Patients

from JAMA Clinical Reviews

As people age, loss of muscle mass is inevitable, resulting in sarcopenia. Muscle loss contributes to overall weakness, which causes frailty. Frailty, in turn, is the generalized susceptibility to disease and injury, all of which causes loss of autonomy. Because of the potential for progressive decline in physical function in very elderly patients, accurate tools are needed to predict mortality risk to individualize treatments intended to improve longevity such as chemotherapy, management of chronic diseases, and surgery. In this podcast, sarcopenia, frailty, and risk prediction are discussed in the context of major trials studying them being conducted in Europe.

Episode metadata supplied by the publisher feed · Published Feb 9, 2017

Embed this episode

NOW PLAYING

Sarcopenia, Frailty and Risk Prediction in Geriatric Patients

0:00 18:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 18 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on February 9, 2017.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!